About
Dr Mohammed Abdul-latif is a Consultant Clinical Oncologist with a specialist interest in urological and gynaecological malignancies, as well as complex brachytherapy. He serves as the Clinical Lead for the brachytherapy department at Mount Vernon Cancer Centre, where he delivers advanced brachytherapy treatments for a range of cancers.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mohammed Abdul-latif
Education & training
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncology
-
2012–2013 Fellowship · Subspecialty training
Career & appointments
-
2012-09–2013-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 5,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,413 |
| Annual physical exam | 99395 | 435 |
| Vaccination administration | 90471 | 2,499 |
| Minor procedure (skin) | 17110 | 2,868 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 19 · i10: 7
-
European registry analysis of Oncology outcomes
DOI: 10.5319/euroclin.2025.0 · PMID: 35622372 · cited by 85
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.5304/euroclin.2024.1 · PMID: 34197352 · cited by 151
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · Northwood · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — Northwood · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2013
- national college of family doctors — Member · Since 2013
- European Union of Medical Specialists (UEMS) — Member · Since 2013
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · mohammed.abdul.latif@euroclinics.example
- Accepted international insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Location
1 tagPatient reviews
1 verified reviews5.00
★★★★★
1 review
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
